Differential effects of simvastatin on mesangial cells
Open Access
- 1 July 2004
- journal article
- Published by Elsevier in Kidney International
- Vol. 66 (1) , 187-195
- https://doi.org/10.1111/j.1523-1755.2004.00710.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural ChangesCirculation Research, 2003
- Anti-inflammatory and immunomodulatory effects of statinsKidney International, 2003
- Rho‐dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins)British Journal of Pharmacology, 2001
- Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular diseaseCardiovascular Research, 2001
- Induction of Connective Tissue Growth Factor by Activation of Heptahelical ReceptorsPublished by Elsevier ,2000
- Potentiation of Rho-A-mediated Lysophosphatidic Acid Activity by HyperinsulinemiaJournal of Biological Chemistry, 2000
- Low-Density Lipoprotein-Induced Expression of Interleukin-6, a Marker of Human Mesangial Cell Inflammation: Effects of Oxidation and Modulation by LovastatinBiochemical and Biophysical Research Communications, 2000
- Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cellsKidney International, 1999
- Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatinKidney International, 1995
- Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodiaCell, 1995